Enterprise Value
22.94M
Cash
1.803M
Avg Qtr Burn
-8.224M
Short % of Float
4.77%
Insider Ownership
0.50%
Institutional Own.
11.31%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MultiStem (MASTERS-2) Details Ischemic stroke | Phase 3 Update | |
MultiStem (MACoVIA) Details Acute respiratory distress syndrome, COVID-19 | Phase 2/3 Update | |
Phase 2 Update |